NCT06634173 The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer Status NOT_YET_RECRUITING Phase NA
NCT06627530 COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06626386 Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap) Status RECRUITING Phase N/A
NCT06625970 Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse Status RECRUITING Phase PHASE3
NCT06614751 A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway Status NOT_YET_RECRUITING Phase PHASE1
NCT06613100 Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer Status RECRUITING Phase PHASE1
NCT06612047 Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer Status RECRUITING Phase N/A
NCT06604442 Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Status COMPLETED Phase PHASE4
NCT06604377 Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features Status COMPLETED Phase N/A
NCT06604247 The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients Status COMPLETED Phase NA
NCT06601205 Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer. Status COMPLETED Phase PHASE2/PHASE3
NCT06600698 Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA Status RECRUITING Phase PHASE1/PHASE2
NCT06599476 Rectal Spacers in Prostate Cancer Patients Undergoing Radiation Therapy Status ACTIVE_NOT_RECRUITING Phase NA